DeepMed Research

Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1873-01-01

Employees: 10K

Market Cap: -

Website: http://www.vanderbilt.edu

Clinical Trials

Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study

Phase 1

Completed

Conditions: Inflammation

Interventions: Drug: Intravitreal Ketorolac

First Posted Date: 2010-07-16

Last Posted Date: 2013-12-31

Lead Sponsor: Vanderbilt University

Target Recruit Count: 10

Registration Number: NCT01164085

Locations: 🇺🇸
Vanderbilt Eye Institute, Nashville, Tennessee, United States

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study

Completed

Conditions: Macular Pucker
Glaucoma
Vitreomacular Traction
Macula Hole
Vitreous Opacities or Hemorrhage

First Posted Date: 2010-07-14

Last Posted Date: 2017-02-23

Lead Sponsor: Vanderbilt University

Target Recruit Count: 45

Registration Number: NCT01162356

Locations: 🇺🇸
Vanderbilt Eye Institute, Nashville, Tennessee, United States

Oxidative Stress in Chronic Kidney Disease: Diet and Exercise

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Other: caloric restriction
Other: aerobic exercise

First Posted Date: 2010-06-28

Last Posted Date: 2014-07-25

Lead Sponsor: Vanderbilt University

Target Recruit Count: 122

Registration Number: NCT01150851

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
Springfield College, Springfield, Massachusetts, United States
🇺🇸
Kidney Research Institute, Seattle, Washington, United States

and more 1 locations

Atrial Fibrillation/Flutter Outcome Risk Determination

Completed

Conditions: Atrial Fibrillation
Atrial Flutter

First Posted Date: 2010-06-07

Last Posted Date: 2015-04-29

Lead Sponsor: Vanderbilt University

Target Recruit Count: 519

Registration Number: NCT01138644

Locations: 🇺🇸
Vanderbilt University Medical Center - Emergency Medicine, Nashville, Tennessee, United States

Autonomic Nervous System and Nitric Oxide Interactions

Phase 1

Completed

Conditions: Endothelial Dysfunction

Interventions: Drug: Placebo
Drug: Trimethaphan

First Posted Date: 2010-06-04

Last Posted Date: 2018-02-28

Lead Sponsor: Vanderbilt University

Target Recruit Count: 21

Registration Number: NCT01137253

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Achieving Medication Safety During Acute Kidney Injury

Not Applicable

Completed

Conditions: Kidney Failure, Acute

Interventions: Other: Pharmacy Dashboard Review and Intervention

First Posted Date: 2010-06-02

Last Posted Date: 2012-02-27

Lead Sponsor: Vanderbilt University

Target Recruit Count: 540

Registration Number: NCT01134900

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Cognitive-Behavioral Physical Therapy

Phase 1

Completed

Conditions: Spinal Stenosis

Interventions: Behavioral: CBPT
Other: Control-Attention

First Posted Date: 2010-05-27

Last Posted Date: 2014-07-04

Lead Sponsor: Vanderbilt University

Target Recruit Count: 86

Registration Number: NCT01131611

Locations: 🇺🇸
Vanderbilt Orthopaedic Institute, Nashville, Tennessee, United States

MRI Thermal Imaging of Infants Undergoing Cooling for Hypoxic Ischemic Encephalopathy(HIE)

Withdrawn

Conditions: Hypoxic Ischemic Encephalopathy

Interventions: Device: mRI

First Posted Date: 2010-05-24

Last Posted Date: 2015-06-03

Lead Sponsor: Vanderbilt University

Registration Number: NCT01128673

Locations: 🇺🇸
Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, United States

Online Resources to Manage Obesity and Health Risks in an Employee Wellness Program

Not Applicable

Completed

Conditions: Obesity

Interventions: Other: Goal-Setting Tool
Other: Health Web Sites

First Posted Date: 2010-05-13

Last Posted Date: 2013-08-22

Lead Sponsor: Vanderbilt University

Target Recruit Count: 12

Registration Number: NCT01122420

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Acetaminophen to Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention for Acute Myocardial Infarction

Not Applicable

Withdrawn

Conditions: Acute Myocardial Infarction

Interventions: Drug: Acetaminophen
Drug: Placebo

First Posted Date: 2010-05-11

Last Posted Date: 2015-12-07

Lead Sponsor: Vanderbilt University

Registration Number: NCT01120769

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy